ACHIEVE LIFE SCIENCES, INC. (ACHV) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US0044685008
ACHIEVE LIFE SCIENCES, INC. financials
| Fiscal year | 2025 |
|---|---|
| EBIT | -55.32 m USD |
| Net income | -54.65 m USD |
| Diluted EPS – continuing operations | -1.25 USD |
Full history since 1994, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About ACHIEVE LIFE SCIENCES, INC.
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
More stocks
- Capital Bancorp Inc (CBNK)
- Shandong Shanda Wit Science and Technology Co Ltd (000915.SZ)
- Jacquet Metals SA (JCQ.PA)
- Zhejiang Shengyang Science (603703.SS)
- GuangDong Rifeng Electric Cable Co Ltd (002953.SZ)
- COFCO Joycome Foods Ltd (1610.HK)
- New Huadu Supercenter Co Ltd (002264.SZ)
- PMB Technology Bhd (7172.KL)
- North American Income Trust PLC (NAIT.L)
- Oneness Biotech Co Ltd (4743.TWO)
- Shenzhen Fuanna Bedding and Furnishing Co Ltd (002327.SZ)
- Granite Ridge Resources, Inc. (GRNT)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.